Key result
New protocol details a planned systematic review of percutaneous treatments for calcified CAD.
Why the study?
Severely calcified coronary stenoses complicate PCI and increase procedural risks, yet these patients are often excluded from trials, leaving little evidence on optimal treatment.
Do various percutaneous treatment options (lesion preparation, stenting, postdilatation) improve all-cause mortality and serious adverse events in patients with calcified coronary artery disease undergoing PCI?
Systematic Review
Do various percutaneous treatment options (lesion preparation, stenting, postdilatation) improve all-cause mortality and serious adverse events in patients with calcified coronary artery disease undergoing PCI?
This protocol outlines a planned systematic review and network meta-analysis to evaluate the efficacy and safety of various percutaneous treatment options for severely calcified coronary stenoses.
Answers are grounded in this paper and cite their sources.
Protocol signals evidence gap for calcified CAD PCI; leaves open optimal lesion preparation strategies pending synthesis.
INTRODUCTION: Severely calcified coronary stenoses are difficult to treat with percutaneous coronary interventions. The presence of severe calcifications complicates lesion preparation, advancement of stents and achievement of full stent expansion. Intervention in these lesions is associated with an increased risk of complications and procedural failure compared with treatment of less calcified lesions. Due to the high burden of comorbidity, patients with severely calcified lesions are often excluded from interventional trials, and there is little evidence on how to treat these patients. METHODS AND ANALYSIS: We will conduct a systematic review of randomised trials enrolling patients with calcified coronary artery disease undergoing percutaneous coronary intervention. We will investigate any percutaneous treatment option including any lesion preparation, stenting or postdilatation technique. We will search The Cochrane Central Register of Controlled Trials, Medical Literature Analysis and Retrieval System Online, Latin American and Caribbean Health Sciences Literature, Science Citation Index Expanded, and Excerpta Medica database for studies from inception to 31 October 2022. The coprimary outcome is all-cause mortality and serious adverse events. If appropriate, we will conduct meta-analysis, trial sequential analysis and network meta-analysis. ETHICS AND DISSEMINATION: No ethics approval is required for this study. The results will be published in a peer-reviewed journal in this field. PROSPERO REGISTRATION NUMBER: CRD42021226034.
No takes yet. Share an insight, caveat, or question.
Kristensen et al. (2022) conducted a systematic review in calcified coronary artery disease. percutaneous treatment options (lesion preparation, stenting, postdilatation) was evaluated on all-cause mortality and serious adverse events. This protocol outlines a planned systematic review and meta-analysis to evaluate percutaneous treatment options for patients with calcified coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: